All lobbying filings

W STRATEGIES, LLC

Lobbying for ABBOTT LABORATORIES · A pharmaceuticals health care company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 15, 2025

Official filing document

Bills named in this filing 1

HR 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…

Lobbying activity 1

Health Issues

Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.